Gypenoside inhibits interleukin‐1β‐induced inflammatory response in human osteoarthritis chondrocytes

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of biochemical and molecular toxicology

• Publication date

  2017-04-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jbt.21926PMID 28422402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gypenoside Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of Mitogen-Activated Protein Kinase Mediated Nuclear Factor Kappa B Pathway In Vitro and In Vivo

  2016cited by this paper
• Gypenoside attenuates renal ischemia/reperfusion injury in mice by inhibition of ERK signaling.

  2016cited by this paper
• The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis

  2014cited by this paper
• FRI0319 Levels of IL-1β and MMP-3 are increased in the synovial fluid from knee osteoarthritis (OA) in patients with concomitant erosive hand OA

  2013cited by this paper
• Piperine inhibits IL-β induced expression of inflammatory mediators in human osteoarthritis chondrocyte.

  2013cited by this paper
• Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats

  2012cited by this paper
• Gypenoside attenuates white matter lesions induced by chronic cerebral hypoperfusion in rats.

  2011cited by this paper
• Prostaglandin E2 regulates the expression of connective tissue growth factor (CTGF/CCN2) in human osteoarthritic chondrocytes via the EP4 receptor

  2010cited by this paper
• Diagnosis and treatment of osteoarthritis.

  2010cited by this paper
• Phytoestrogen bavachin mediates anti-inflammation targeting Ikappa B kinase-I kappaB alpha-NF-kappaB signaling pathway in chondrocytes in vitro.

  2010cited by this paper
• Species distribution and susceptibility profile of Candida species in a Brazilian public tertiary hospital

  2010cited by this paper
• Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis.

  2009cited by this paper
• Correlation of gene and mediator expression with clinical endpoints in an acute interleukin-1beta-driven model of joint pathology.

  2009cited by this paper
• Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes.

  2008cited by this paper
• The Interleukin 1β Pathway in the Pathogenesis of Osteoarthritis

  2008cited by this paper
• Interleukin-1β induced activation of nuclear factor-κb can be inhibited by novel pharmacological agents in osteoarthritis

  2007cited by this paper
• Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis.

  2007cited by this paper
• Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone.

  2007cited by this paper
• NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis

  2006cited by this paper
• NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis.

  2006cited by this paper
• Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.

  2005cited by this paper
• Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes.

  2003cited by this paper
• Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes

  2003cited by this paper
• Roles for homotypic interactions and transautophosphorylation in IkappaB kinase beta IKKbeta) activation [corrected].

  2003cited by this paper
• Roles for Homotypic Interactions and Transautophosphorylation in IκB Kinase (IKKβ) Activation*

  2003cited by this paper
• Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-kappaB-mediated iNOS protein expression.

  2003cited by this paper
• Expression of membrane‐type 1 matrix metalloproteinase in rheumatoid synovial cells

  2001cited by this paper
• Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets.

  2001cited by this paper
• Effect of interleukin 1 on articular cartilage from young and aged horses and comparison with metabolism of osteoarthritic cartilage.

  1994cited by this paper
• Protective Effect of Gypenosides Against Oxidative Stress in Phagocytes, Vascular Endothelial Cells and Liver Microsomes

  1993cited by this paper
• Role of metalloproteinases in human osteoarthritis.

  1991cited by this paper

• Advances in the pathology and treatment of osteoarthritis

  2025cites this paper
• Gypenosides, a promising phytochemical triterpenoid: research progress on its pharmacological activity and mechanism

  2025cites this paper
• Gypenoside A Protects Human Myocardial Cells from Ischemia/Reperfusion Injury via the circ_0010729/miR-370-3p/RUNX1 Axis

  2024cites this paper
• Neuroprotective Effects of Gypenosides and Their Underlying Mechanisms

  2023cites this paper
• Circ_0001721 knockdown relieves IL-1β-induced chondrocyte injury via regulating miR-373-3p/CXCR4 in osteoarthritis.

  2023cites this paper
• Production of Gypenoside XVII from Ginsenoside Rb1 by Enzymatic Transformation and Their Anti-Inflammatory Activity In Vitro and In Vivo

  2023cites this paper
• Therapeutic Effect of Gypenosides on Antioxidant Stress Injury in Orbital Fibroblasts of Graves' Orbitopathy

  2022cites this paper
• l‐Arginine prevents 4‐hydroxy‐2‐nonenal accumulation and depresses inflammation via inhibiting NF‐κB activation

  2022cites this paper
• Gypenoside ameliorates insulin resistance and hyperglycemia via the AMPK-mediated signaling pathways in the liver of type 2 diabetes mellitus mice

  2022cites this paper
• Activity Components from Gynostemma pentaphyllum for Preventing Hepatic Fibrosis and of Its Molecular Targets by Network Pharmacology Approach

  2021cites this paper
• Nutraceuticals in arthritis

  2021cites this paper
• Gypenosides modulate NCX calcium flux, insulin secretion and cytoprotection in BRIN-BD11 pancreatic β-cells

  2021cites this paper
• Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA-21-mediated PTEN/AKT/mTOR pathway

  2021cites this paper
• NLRC5 attenuates inflammatory response in IL-1β-stimulated human osteoarthritis chondrocytes through the NF-κB signaling pathway

  2021cites this paper
• Gypenoside XLIX loaded nanoparticles targeting therapy for renal fibrosis and its mechanism.

  2021cites this paper
• Research Progress on the Antiosteoarthritic Mechanism of Action of Natural Products

  2021cites this paper
• New anti-proliferative triterpenes from hydrolyzate of total Gynostemma pentaphyllum saponins induces cell cycle arrest and apoptosis in human breast cancer cells

  2021cites this paper
• Gypenosides Protect Orbital Fibroblasts in Graves Ophthalmopathy via Anti-Inflammation and Anti-Fibrosis Effects

  2020cites this paper
• Triterpenoids from the genus Gynostemma: Chemistry and pharmacological activities.

  2020cites this paper
• Herbal Medicine for Slowing Aging and Aging-Associated Conditions: Efficacy, Mechanisms, and Safety.

  2020cites this paper
• Gypenosides mediate cholesterol efflux and suppress oxidized LDL induced inflammation in retinal pigment epithelium cells.

  2020cites this paper
• Therapeutic Efficacy and Safety Evaluation of Flex ChoiceTM in Moderately Osteoarthritic Dogs*

  2020cites this paper
• Research on the Potential Mechanism of Gypenosides on Treating Thyroid-Associated Ophthalmopathy Based on Network Pharmacology

  2019cites this paper
• Chondroprotective Effects of Genistein against Osteoarthritis Induced Joint Inflammation

  2019cites this paper
• Osteoarthritis Biomarkers

  2019cites this paper
• Chondroprotective and antiarthritic effects of daphnetin used in vitro and in vivo osteoarthritis models.

  2019cites this paper
• Gypenosides attenuate lipopolysaccharide-induced optic neuritis in rats.

  2018cites this paper
• Scoparone prevents IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through the PI3K/Akt/NF-κB pathway.

  2018cites this paper
• Gypenosides reverses depressive behavior via inhibiting hippocampal neuroinflammation.

  2018cites this paper
• Gypenoside inhibits RANKL‐induced osteoclastogenesis by regulating NF‐κB, AKT, and MAPK signaling pathways

  2018cites this paper
• Gypenosides protect retinal pigment epithelium cells from oxidative stress.

  2018cites this paper
• New dammarane-type triterpene saponins from Gynostemma pentaphyllum and their anti-hepatic fibrosis activities in vitro

  2018cites this paper